India and the United States are negotiating the contours of their post-tariff economic relationship this week, as trade officials from both countries convene in Washington to build on February's breakthrough agreement that reduced US tariffs on Indian goods from 25% to 18%.
The talks, running from April 20-22, are led for India by Darpan Jain, Additional Secretary in the Department of Commerce, and represent the first formal trade discussions since the February 2026 deal that eliminated a separate 25% ad valorem tariff linked to India's Russian oil purchases. The February agreement, locked in through an executive order on February 6, created the foundation for what both sides now acknowledge must become a more comprehensive trade architecture.
Beyond the Tariff Reset
The February tariff reduction was a tactical victory, but the current Washington negotiations will test whether both countries can construct a durable framework for economic integration. The talks are forcing a complete rethink of bilateral trade agreement structures, moving beyond the piecemeal tariff adjustments that have characterised India-US trade relations for the past decade.
Two outstanding Section 301 investigations remain on the agenda, creating pressure points that both delegations must navigate. These investigations, launched by the US Trade Representative, target specific Indian trade practices and carry the potential for additional tariffs if left unresolved. The April discussions are expected to address pathways for closing these investigations without triggering new trade friction.
For India, the negotiations offer an opportunity to secure market access commitments that go far beyond tariff rates. Indian services exports have grown significantly in recent years and require predictable regulatory frameworks in the US market. The technology sector needs clarity on data flows, digital services taxation, and the movement of skilled professionals.
Strategic Technology Exports
Both countries maintain export control regimes that limit trade in strategic technologies, creating a complex regulatory landscape that the current talks must address. The February joint statement referenced the need for "coordinated approaches to technology cooperation while maintaining national security priorities."
The pharmaceutical sector presents another negotiating challenge. India seeks expanded market access for generic drugs while the US pushes for stronger intellectual property protections. These competing priorities require careful calibration, particularly given the role of affordable medicines in both countries' healthcare systems.
The talks occur against the backdrop of broader strategic alignment between Washington and New Delhi on Indo-Pacific security, critical technology development, and supply chain resilience. This strategic convergence creates political space for economic agreements that would have been difficult to reach in previous years.
Market Access Architecture
Indian negotiators are pushing for service sector commitments that would provide clearer pathways for Indian companies in consulting, information technology, and financial services. The current regulatory framework creates uncertainty that limits Indian investment in US operations and constrains the growth potential of bilateral services trade.
The US delegation is focused on securing commitments on digital governance, particularly around data localisation requirements and cross-border data flows. American companies operating in India have faced increasing regulatory complexity in these areas, creating friction that the current talks aim to resolve.
Both sides recognise that the February tariff agreement was a confidence-building measure rather than a comprehensive solution. The April negotiations test whether that confidence can translate into institutional frameworks that survive political transitions in both countries.
The timeline pressure is significant, as both delegations face domestic constituencies that expect concrete outcomes from the improved bilateral relationship. For India, demonstrating progress on market access supports the broader economic modernisation agenda that underpins long-term growth targets.
Implementation Frameworks
Beyond specific sector agreements, the talks address implementation mechanisms that would provide ongoing forums for resolving trade disputes before they escalate to formal investigations or tariff actions. The February agreement created momentum, but sustaining it requires institutional infrastructure that can manage the inevitable friction points in a complex bilateral relationship.
The pharmaceutical discussion is particularly complex, as it touches on pricing mechanisms, regulatory approval processes, and patent protections that affect both countries' domestic markets. Finding common ground requires balancing innovation incentives with healthcare accessibility concerns that resonate politically in both Washington and New Delhi.
The April talks represent a critical test of whether the strategic partnership between India and the US can generate economic agreements that match the scope of security cooperation. Success would create a template for trade relationships that support both countries' strategic autonomy while deepening economic integration. Failure would limit the partnership to security cooperation while leaving economic potential unrealised, constraining India's access to advanced technology markets and limiting US companies' participation in India's economic expansion.